Endo Manufacturing (7841) Fundamentals 2026 — P/E 16.7x, Revenue Analysis | SniperIQ
Endo Manufacturing (7841) is a JP-listed Industrials company in Manufacturing - Metal Fabrication with a market capitalization of ¥9.6B, trading at ¥1090.00 on the JPX. This SniperIQ fundamentals page covers Endo Manufacturing's valuation (P/E 16.7x, P/B 0.4x), profitability (net margin 3.1%), revenue (¥18.2B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Endo Manufacturing's market cap?
Endo Manufacturing (7841) has a market capitalization of approximately ¥9.6B, trading at ¥1090.00 on the JPX. Market cap moves with the live share price.
What is Endo Manufacturing's P/E ratio?
Endo Manufacturing's trailing twelve-month P/E ratio is 16.7x, with a price-to-book (P/B) of 0.4x. Valuation multiples are best compared with Industrials sector peers rather than read in isolation.
How profitable is Endo Manufacturing?
Endo Manufacturing runs a net profit margin of 3.1%, a gross margin of 15.9%, and an operating margin of 5.6%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Endo Manufacturing generate?
Endo Manufacturing reported revenue of ¥18.2B for fiscal year 2025, with net income of ¥601M and earnings per share (EPS) of 68.42. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Endo Manufacturing pay a dividend?
Endo Manufacturing offers a trailing dividend yield of about 3.7%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Endo Manufacturing financially healthy?
Endo Manufacturing carries a debt-to-equity ratio of 0.00x and a current ratio of 4.99x, with a market beta of 0.30. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Endo Manufacturing a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Endo Manufacturing (7841) the key facts are: market cap ¥9.6B, P/E 16.7x, revenue ¥18.2B, 52-week range 1040-1364. Weigh valuation, profitability, growth, and balance-sheet strength against Industrials peers and form your own view.
Track Endo Manufacturing's full fundamentals live
Get Endo Manufacturing's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.